{"id":"https://openalex.org/W2052800274","doi":"https://doi.org/10.1097/01.asn.0000120180.56818.9e","title":"Statins\u2019 Coat of Many Colors Receives Yet Another Hue","display_name":"Statins\u2019 Coat of Many Colors Receives Yet Another Hue","publication_year":2004,"publication_date":"2004-04-01","ids":{"openalex":"https://openalex.org/W2052800274","doi":"https://doi.org/10.1097/01.asn.0000120180.56818.9e","mag":"2052800274","pmid":"https://pubmed.ncbi.nlm.nih.gov/15034117"},"language":"en","primary_location":{"id":"doi:10.1097/01.asn.0000120180.56818.9e","doi":"https://doi.org/10.1097/01.asn.0000120180.56818.9e","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.asn.0000120180.56818.9e","pdf_url":null,"source":{"id":"https://openalex.org/S115693375","display_name":"Journal of the American Society of Nephrology","issn_l":"1046-6673","issn":["1046-6673","1533-3450"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315620","host_organization_name":"American Society of Nephrology","host_organization_lineage":["https://openalex.org/P4310315620"],"host_organization_lineage_names":["American Society of Nephrology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Society of Nephrology","raw_type":"journal-article"},"volume":null,"type":"editorial","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5050906977","display_name":"Michael S. Goligorsky","orcid":"https://orcid.org/0000-0003-0561-4469","observed_orcids":["https://orcid.org/0000-0003-0561-4469"]},"institutions":[{"id":"https://openalex.org/I181190671","display_name":"New York Medical College","ror":"https://ror.org/03dkvy735","country_code":"US","type":"education","lineage":["https://openalex.org/I181190671"]},{"id":"https://openalex.org/I4210124297","display_name":"Renal Research Institute","ror":"https://ror.org/032g46r36","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210124297"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Michael S. Goligorsky","raw_affiliation_strings":["Departments of Medicine and Pharmacology and Renal Research Institute, New York Medical College, Valhalla, New York","to Dr. Michael S. Goligorsky, Renal Research Institute, new York Medical College, Valhalla, NY 10595. Phone: 914-594-4731; Fax: 914-594-4732; E-mail: [email\u00a0protected]","E-mail: [email\u00a0protected]","Fax: 914-594-4732"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Medicine and Pharmacology and Renal Research Institute, New York Medical College, Valhalla, New York","institution_ids":["https://openalex.org/I181190671","https://openalex.org/I4210124297"]},{"raw_affiliation_string":"to Dr. Michael S. Goligorsky, Renal Research Institute, new York Medical College, Valhalla, NY 10595. Phone: 914-594-4731; Fax: 914-594-4732; E-mail: [email\u00a0protected]","institution_ids":["https://openalex.org/I181190671","https://openalex.org/I4210124297"]},{"raw_affiliation_string":"E-mail: [email\u00a0protected]","institution_ids":[]},{"raw_affiliation_string":"Fax: 914-594-4732","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5100370077","display_name":"Wen\u2010Hui Wang","orcid":"https://orcid.org/0000-0002-7503-9554","observed_orcids":["https://orcid.org/0000-0002-7503-9554"]},"institutions":[{"id":"https://openalex.org/I181190671","display_name":"New York Medical College","ror":"https://ror.org/03dkvy735","country_code":"US","type":"education","lineage":["https://openalex.org/I181190671"]},{"id":"https://openalex.org/I4210124297","display_name":"Renal Research Institute","ror":"https://ror.org/032g46r36","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210124297"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wenhui Wang","raw_affiliation_strings":["Departments of Medicine and Pharmacology and Renal Research Institute, New York Medical College, Valhalla, New York","E-mail: [email\u00a0protected]","Fax: 914-594-4732"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Medicine and Pharmacology and Renal Research Institute, New York Medical College, Valhalla, New York","institution_ids":["https://openalex.org/I181190671","https://openalex.org/I4210124297"]},{"raw_affiliation_string":"E-mail: [email\u00a0protected]","institution_ids":[]},{"raw_affiliation_string":"Fax: 914-594-4732","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5050906977"],"corresponding_institution_ids":["https://openalex.org/I181190671","https://openalex.org/I4210124297"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"15","issue":"4","first_page":"1098","last_page":"1100"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12465","display_name":"Cancer, Lipids, and Metabolism","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/statins","display_name":"statins","score":0.9340000152587891},{"id":"https://openalex.org/keywords/cardiovascular-disease","display_name":"cardiovascular disease","score":0.6919999718666077},{"id":"https://openalex.org/keywords/chronic-kidney-disease","display_name":"chronic kidney disease","score":0.8980000019073486},{"id":"https://openalex.org/keywords/hypercholesterolemia","display_name":"hypercholesterolemia","score":0.8500000238418579},{"id":"https://openalex.org/keywords/c-reactive-protein","display_name":"C-reactive protein","score":0.7020000219345093},{"id":"https://openalex.org/keywords/homocysteine","display_name":"homocysteine","score":0.7900000214576721},{"id":"https://openalex.org/keywords/tissue-plasminogen-activator","display_name":"tissue plasminogen activator","score":0.7990000247955322},{"id":"https://openalex.org/keywords/plasminogen-activator-inhibitor-1","display_name":"plasminogen activator inhibitor-1","score":0.9670000076293945},{"id":"https://openalex.org/keywords/platelet-aggregation","display_name":"platelet aggregation","score":0.871999979019165},{"id":"https://openalex.org/keywords/ldl-oxidation","display_name":"LDL oxidation","score":0.9129999876022339},{"id":"https://openalex.org/keywords/atherosclerosis","display_name":"atherosclerosis","score":0.6959999799728394},{"id":"https://openalex.org/keywords/cardiovascular-risk-reduction","display_name":"cardiovascular risk reduction","score":0.44600000977516174}],"concepts":[{"id":"https://openalex.org/C2777817576","wikidata":"https://www.wikidata.org/wiki/Q1817674","display_name":"Coat","level":2,"score":0.7621299028396606},{"id":"https://openalex.org/C126537357","wikidata":"https://www.wikidata.org/wiki/Q372948","display_name":"Hue","level":2,"score":0.6997976303100586},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4839775562286377},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.26907458901405334},{"id":"https://openalex.org/C154945302","wikidata":"https://www.wikidata.org/wiki/Q11660","display_name":"Artificial intelligence","level":1,"score":0.23825562000274658},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.09991520643234253},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D001808","descriptor_name":"Blood Vessels","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D024681","descriptor_name":"Potassium Channels, Calcium-Activated","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/01.asn.0000120180.56818.9e","doi":"https://doi.org/10.1097/01.asn.0000120180.56818.9e","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.asn.0000120180.56818.9e","pdf_url":null,"source":{"id":"https://openalex.org/S115693375","display_name":"Journal of the American Society of Nephrology","issn_l":"1046-6673","issn":["1046-6673","1533-3450"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315620","host_organization_name":"American Society of Nephrology","host_organization_lineage":["https://openalex.org/P4310315620"],"host_organization_lineage_names":["American Society of Nephrology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Society of Nephrology","raw_type":"journal-article"},{"id":"pmid:15034117","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15034117","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Society of Nephrology : JASN","raw_type":"Comment"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":14,"referenced_works":["https://openalex.org/W1479880028","https://openalex.org/W1579034036","https://openalex.org/W2009086632","https://openalex.org/W2071124826","https://openalex.org/W2074931144","https://openalex.org/W2094894194","https://openalex.org/W2098946775","https://openalex.org/W2103636227","https://openalex.org/W2108116605","https://openalex.org/W2121165964","https://openalex.org/W2155853522","https://openalex.org/W2162779892","https://openalex.org/W2165968739","https://openalex.org/W3157733030"],"related_works":["https://openalex.org/W4235342727","https://openalex.org/W2048682878","https://openalex.org/W2020476431","https://openalex.org/W2040398044","https://openalex.org/W1971218875","https://openalex.org/W2042109453","https://openalex.org/W2162958882","https://openalex.org/W1988019172","https://openalex.org/W3013315694","https://openalex.org/W2156079200"],"abstract_inverted_index":{"With":[0],"cardiovascular":[1,139],"disease":[2,88],"(CVD)":[3],"being":[4],"the":[5,14,17,21,37,55,107,121,158,173,205,208,216,230,274,280,294,303,314,327,331,342,372,378,400,425,450,496,506,522,531,552,588,605,619,652,684,697,734,770,799,809,813,820,852,865,868,876,887,913,920,925,936,942,951,955,959,981,997,1018,1021,1084,1093,1129,1133,1143,1161,1187,1190,1199,1205,1217,1246,1254,1263,1270],"ultimate":[6],"cause":[7],"of":[8,10,16,23,50,83,109,114,123,138,167,175,186,207,218,241,270,282,287,296,308,318,334,347,360,363,366,374,380,384,399,406,424,428,433,444,453,459,472,480,499,519,524,540,544,554,559,570,579,599,602,609,621,651,659,664,672,680,686,701,712,743,763,772,779,791,808,824,854,857,864,867,879,889,898,906,917,945,950,958,983,999,1009,1020,1064,1095,1175,1192,1219,1221,1227,1251,1273],"half":[9],"all":[11,862],"deaths":[12],"in":[13,131,141,161,256,279,337,377,448,467,482,551,564,627,675,696,733,837,840,886,910,947,962,1012,1059,1077,1083,1198,1235,1244],"population":[15],"developed":[18],"countries":[19],"(1),":[20],"dimensions":[22],"this":[24,429,456,622,702,756,765,773,845,907,1039,1060,1109,1168],"modern":[25],"epidemic":[26],"can":[27],"be":[28,154,466,731,979,991,1015,1106,1114,1126,1184,1233],"readily":[29],"appreciated.":[30],"Among":[31,1090],"patients":[32,84,237,265],"with":[33,44,54,85,182,238,249,260,495,1128],"chronic":[34,86],"renal":[35,87],"disease,":[36],"statistical":[38],"figures":[39],"are":[40,221,396,611,617,632,1086,1177],"even":[41],"more":[42,720],"staggering,":[43],"an":[45,704,782,830,835,880,1076],"approximately":[46],"20-fold":[47],"increased":[48,698,855,881],"risk":[49,137,269],"CVD":[51],"mortality,":[52],"compared":[53,248],"age-matched":[56],"general":[57],"population,":[58],"by":[59,157,224,299,330,351,851,893,929,1069,1101,1132],"and":[60,75,89,96,144,232,301,391,403,419,475,508,536,557,717,726,729,828,954,986,1108,1216],"large":[61],"linked":[62],"to":[63,81,325,465,493,688,691,714,797,806,833,844,941,969,978,990,994,1017,1035,1088,1125,1151,1160,1183,1196,1212,1225,1232,1269],"accelerated":[64],"atherosclerosis":[65,76],"(2,3).":[66],"There":[67],"is":[68,431,463,521,757,1041,1092,1149,1240,1257],"a":[69,112,283,320,681,708,739,758,895,976,1028,1044,1267],"well":[70,576],"established":[71,119,133],"association":[72],"between":[73],"hypercholesterolemia":[74],"(4).":[77],"On":[78],"average,":[79],"50%":[80],"70%":[82],"transplant":[90],"recipients":[91],"exhibit":[92],"hypercholesterolemia,":[93],"elevated":[94],"LDL,":[95],"hypertriglyceridemia":[97],"(5).":[98],"The":[99,441,624,669,903],"3-hydroxy-3-methylglutaryl":[100],"CoA":[101],"(HMG-CoA)":[102],"reductase":[103,353],"inhibitors":[104],"(statins),":[105],"inhibiting":[106,505],"synthesis":[108,373],"L-mevalonic":[110],"acid,":[111],"precursor":[113],"cholesterol,":[115,375],"have":[116,213,490,786,966,989],"been":[117,491,795,967],"firmly":[118],"as":[120,355,389,411,561,1202],"therapy":[122],"choice":[124],"for":[125,223,344,470,476,583,719,777,802,815,924,996,1204],"hyperlipidemia.":[126],"Numerous":[127],"clinical":[128,169,211],"trials":[129,170,234],"(reviewed":[130,336,961],"(6))":[132],"that":[134,220,236,581,678,706,784,1063,1139],"statins":[135,176,219,292,335,489,520,580,610,747,965,1197],"reduced":[136,477],"events":[140,298],"both":[142],"primary":[143],"secondary":[145],"prevention":[146,601],"settings.":[147],"Unexpectedly,":[148],"their":[149,225,542,584],"beneficial":[150,1007],"effects":[151,539,569,578,594,608],"could":[152,730,1014,1105,1158],"not":[153,753,1112],"explained":[155],"entirely":[156],"mere":[159],"reduction":[160,255,307],"LDL":[162,200,481,1141],"cholesterol.":[163],"A":[164],"recent":[165],"analysis":[166],"published":[168],"unequivocally":[171],"demonstrated":[172,1138],"effect":[174,333,586,705,760,783,1097,1264],"on":[177,246,587,1098,1116],"nonlipid":[178],"serum":[179,242,257],"markers":[180],"associated":[181],"CVD,":[183,1194],"e.g.,":[184],"level":[185,240],"C-reactive":[187,635],"protein":[188,417],"homocysteine,":[189],"tissue":[190,642],"plasminogen":[191,193,643,646],"activator,":[192],"activator":[194,647],"inhibitor-1,":[195],"platelet":[196],"aggregation,":[197],"and,":[198],"possibly,":[199],"cholesterol":[201,243,258,946,984,1001,1259],"oxidation":[202],"(7).":[203],"In":[204,455,487,1120],"course":[206],"past":[209],"decade,":[210],"studies":[212],"repeatedly":[214],"emphasized":[215],"actions":[217],"unaccounted":[222],"lipid-lowering":[226,262,332],"effects.":[227],"Specifically,":[228],"(1)":[229],"WOSCOP":[231],"CARE":[233],"showed":[235,277,306,677,822],"comparable":[239,254],"fared":[244],"better":[245],"statin":[247,660,682],"placebo":[250],"therapy;":[251],"(2)":[252],"despite":[253],"achieved":[259],"various":[261,548],"therapies,":[263],"statin-treated":[264,483],"exhibited":[266],"much":[267],"lower":[268],"myocardial":[271],"infarction;":[272],"(3)":[273],"FATS":[275],"trial":[276,305],"that,":[278],"face":[281],"marginal":[284],"0.7%":[285],"regression":[286],"angiographically":[288],"detected":[289],"atherosclerotic":[290],"lesion,":[291],"decreased":[293],"incidence":[295],"coronary":[297,310],"70%;":[300],"(4)":[302],"MIRACL":[304],"recurrent":[309],"ischemia":[311],"already":[312],"within":[313,1002],"first":[315],"4":[316],"mo":[317],"therapy,":[319],"time":[321],"frame":[322],"too":[323],"short":[324,710],"explain":[326,912],"benefit":[328],"exclusively":[329],"(8)).":[338],"These":[339,394,535],"observations":[340,1081,1210],"set":[341],"stage":[343],"systematic":[345],"investigation":[346],"alternative":[348],"products":[349,383,395],"suppressed":[350],"HMG-CoA":[352,367],"inhibition":[354,430,458],"potential":[356,1118],"mechanism":[357,923,977,1040,1248],"or":[358,597,761,1031,1249,1261],"mechanisms":[359,1104,1250],"cholesterol-independent":[361],"action":[362,452,518,916,1110],"statins.":[364,454,571],"Inhibition":[365],"reductase,":[368],"apart":[369],"from":[370],"blocking":[371],"results":[376,1123],"depletion":[379,944,998],"other":[381,537,746],"downstream":[382],"mevalonate":[385,725],"metabolism:":[386],"isoprenoids,":[387],"such":[388,407,975,1154],"farnesylpyrophosphate":[390],"geranylgeranylpyrophosphate":[392],"(9).":[393],"critical":[397],"elements":[398],"posttranslational":[401],"modification":[402,479],"subcellular":[404],"localization":[405],"ubiquitous":[408],"signaling":[409],"proteins":[410],"G-proteins,":[412],"small":[413],"guanosine":[414,859],"triphosphate":[415],"(GTP)-binding":[416],"Ras,":[418],"Rho":[420],"family":[421],"members.":[422],"One":[423,933],"important":[426,787,1172],"consequences":[427],"stimulation":[432],"endothelial":[434,473,525,693,780,841,1010,1065,1213,1222],"nitric":[435],"oxide":[436],"synthase":[437],"(eNOS)":[438],"expression":[439],"(10,11).":[440],"universal":[442],"nature":[443],"these":[445,615,792,1051,1122],"messengers":[446],"explains":[447],"part":[449,468,911],"pleiotropic":[451,538,585],"vein,":[457],"Rac-1-mediated":[460],"oxidative":[461,478],"stress":[462],"believed":[464],"responsible":[469,776],"improvement":[471],"dysfunction,":[474],"cholesterol-fed":[484],"rabbits":[485],"(12,13).":[486],"addition,":[488,1121],"found":[492],"interact":[494],"I":[497],"domain":[498],"leukocyte":[500],"function":[501],"antigen":[502],"(LFA)-1,":[503],"thus":[504,737],"integrin":[507],"consequently":[509],"leukocyte-endothelial":[510],"cell":[511,1066,1214],"interactions":[512],"(14).":[513],"Another":[514,1005],"recently":[515],"identified,":[516],"unexpected":[517],"recruitment":[523],"progenitor":[526],"cells,":[527,781,1026],"which":[528,1176],"occurs":[529],"via":[530,884,900,1027,1075],"PI3-kinase/Akt":[532],"pathway":[533],"(15,16).":[534],"statins,":[541,1070],"\u201ccoat":[543],"many":[545,1171],"colors,\u201d":[546],"target":[547,742],"pathways":[549],"engaged":[550],"development":[553],"vascular":[555,1023,1228],"dysfunction":[556],"progression":[558],"atherosclerosis,":[560],"schematically":[562],"summarized":[563,1178],"Figure":[565],"1.Figure":[566],"1.:":[567],"Vascular":[568],"This":[572,847,872],"summary":[573],"compiles":[574],"only":[575,764],"documented":[577],"account":[582,995],"vasculature.":[589],"Of":[590],"note,":[591],"neither":[592],"nonvascular":[593],"(e.g.,":[595],"suppression":[596],"induction":[598],"proteinuria,":[600],"osteoporosis)":[603],"nor":[604],"adverse":[606],"side":[607],"presented":[612,626,674,1058],"here,":[613],"because":[614],"subjects":[616],"beyond":[618],"focus":[620],"summary.":[623],"findings":[625],"Kuhlmann":[628],"et":[629],"al.":[630],"(17)":[631],"double-framed.":[633],"CRP,":[634],"protein;":[636],"AT-1,":[637],"angiotensin-1;":[638],"ET-1,":[639],"endothelin-1;":[640],"tPA,":[641],"activator;":[644],"PAI-1,":[645],"inhibitor-1.The":[648],"current":[649],"issue":[650],"Journal":[653],"brings":[654],"about":[655],"yet":[656],"another":[657],"mode":[658,897],"action,":[661],"i.e.,":[662],"opening":[663,771,928,1253],"calcium-activated":[665],"potassium":[666,1145,1255],"channels":[667],"(17).":[668],"main":[670],"line":[671],"investigations":[673],"it":[676,1181,1239,1258],"application":[679],"at":[683],"concentration":[685,827],"10":[687],"30":[689,722],"nM":[690],"cultured":[692,1207],"cells":[694,793,842,1223],"resulted":[695],"open":[699],"probability":[700],"channel,":[703],"required":[707],"remarkably":[709],"latency":[711],"15":[713,1003],"20":[715],"min":[716],"lasted":[718],"than":[721],"min,":[723],"was":[724,775,848],"iberiotoxin":[727],"inhibitable":[728],"reproduced":[732],"inside-out":[735],"patches,":[736],"demonstrating":[738],"novel":[740],"direct":[741,1032],"cerivastatin.":[744,1102],"No":[745],"were":[748],"examined,":[749],"so":[750],"we":[751,1049],"do":[752],"know":[754],"whether":[755,1038,1186],"class":[759],"typical":[762],"compound.":[766],"At":[767,1165],"any":[768,1166],"rate,":[769],"channel":[774,927,1146],"hyperpolarization":[778,1011,1019,1220,1226],"may":[785,874,909,1111],"functional":[788],"implications.":[789],"Hyperpolarization":[790],"has":[794],"shown":[796],"increase":[798,836,885],"driving":[800],"force":[801],"calcium":[803,811,826,901],"entry":[804],"leading":[805,940,1034,1224],"elevation":[807,823],"cytosolic":[810,825],"concentration,":[812],"stimulus":[814],"eNOS":[816,882],"activation":[817,866,899,957],"(18,19).":[818],"Indeed,":[819,964],"authors":[821],"used":[829],"NO-sensitive":[831],"fluorophore":[832],"demonstrate":[834],"NO":[838,1099],"generation":[839],"exposed":[843],"statin.":[846],"further":[849],"confirmed":[850],"demonstration":[853],"production":[856,1100],"cyclic":[858],"monophosphate":[860],"(GMP),":[861],"suggestive":[863],"constitutive":[869],"calcium-dependent":[870],"NOS.":[871],"finding":[873,1057],"complement":[875],"previous":[877,1130],"observation":[878,908],"abundance":[883,972],"half-life":[888],"its":[890],"mRNA":[891],"(11)":[892],"providing":[894],"rapid":[896,943],"signaling.":[902],"undoubted":[904],"importance":[905],"strong":[914],"antiatherogenic":[915],"NO.":[918],"However,":[919],"precise":[921],"molecular":[922,1247],"observed":[926],"cerivastatin":[930],"remains":[931],"unclear.":[932],"cannot":[934],"discount":[935],"traditional":[937],"cholesterol-dependent":[938],"route":[939],"lipid-rich":[948],"domains":[949],"plasma":[952],"membrane":[953,1000,1117],"subsequent":[956],"enzyme":[960],"(20)).":[963],"suggested":[968],"reduce":[970],"caveolar":[971],"(21).":[973],"For":[974],"operant,":[980],"rate":[982],"trafficking":[985],"exchange":[987],"would":[988],"quite":[992],"impressive":[993],"min.":[1004],"potentially":[1006],"consequence":[1008],"vivo":[1013,1078],"attributed":[1016],"adjacent":[1022],"smooth":[1024,1229],"muscle":[1025,1230],"hyperpolarizing":[1029],"factor":[1030],"coupling,":[1033],"vasorelaxation.":[1036],"Investigating":[1037],"operant":[1042],"represents":[1043],"reasonably":[1045],"straightforward":[1046],"task,":[1047],"which,":[1048],"hope,":[1050],"investigators":[1052],"will":[1053,1071],"pursue.":[1054],"An":[1055],"additional":[1056],"article,":[1061],"namely":[1062],"proliferation":[1067,1215],"stimulated":[1068],"also":[1072],"require":[1073],"verification":[1074],"system.":[1079],"Several":[1080],"described":[1082,1203],"article":[1085],"difficult":[1087,1150],"interpret.":[1089],"them":[1091],"potentiation":[1094],"acetylcholine":[1096],"Diverse":[1103],"involved,":[1107],"necessarily":[1113],"dependent":[1115],"alone.":[1119],"remain":[1124],"reconciled":[1127],"work":[1131],"same":[1134,1144,1162,1200],"investigators,":[1135],"where":[1136],"they":[1137],"oxidized":[1140],"activates":[1142],"(22).":[1147],"It":[1148],"comprehend":[1152],"how":[1153],"diametrically":[1155],"opposite":[1156],"stimuli":[1157],"lead":[1159],"end":[1163],"effect.":[1164],"event,":[1167],"publication":[1169],"raises":[1170],"issues,":[1173],"some":[1174],"below.":[1179],"First,":[1180],"needs":[1182],"examined":[1185],"dysfunctional":[1188],"endothelium,":[1189],"prodrome":[1191],"diverse":[1193],"responds":[1195],"way":[1201],"intact":[1206],"cells.":[1208],"Second,":[1209],"related":[1211],"possibility":[1218],"need":[1231],"tested":[1234],"vivo.":[1236],"And":[1237],"finally,":[1238],"worth":[1241],"investing":[1242],"effort":[1243],"discovering":[1245],"statin\u2019s":[1252],"channel:":[1256],"dependent,":[1260],"does":[1262],"actually":[1265],"add":[1266],"hue":[1268],"Technicolor":[1271],"coat":[1272],"statins?":[1274]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}